2nd Annual Clinical Trials Excellence

As drug development costs and significant time spent on clinical trials steadily increases and simultaneously, the number of global clinical trials is expected to increase over the next few years, which will bring a huge demand for new patients in almost every disease category. Inefficient patient recruitment can cause clinical trials to last 42% longer than expected in Phase I, 31% longer in Phase II and 30% in Phase III. These delays are extremely costly, estimated $600,000 per day in lost sales and as much as $8 million per day for potential blockbusters.

Followed by the great success of Clinical Trials Excellence forum 2007, the 2nd Annual Clinical Trials Excellence 2008 will further discuss the on-going pressing concerns faced in clinical trials operations, addressing the risks, timeline and budget constraint, whilst effectively tackling key challenges in overcoming trials agreement and site contract negotiation hurdles. This year, the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent & investigators management will be discussed in order to improve and optimise the overall drug development effectiveness and ROI. The 2nd Annual Clinical Trials Excellence Forum will also continue to cover how to implement and benefit from electronic data management & monitoring cost effectively.

At the 2nd Annual Clinical Trials Excellence 2008, best practice models will be shared by leading industrial practitioners across the region to promote practical discussions; especially on the know-how to manage needs, variability of different countries and institutions to enhance clinical operational excellence and vigilance. Delegates will have the opportunity to learn, network and benchmark against the global top pharmas and local industry leaders on the best practices in talent, site, budget and performance management in clinical trials.

Key benefits of attending this event:

This interactive forum featuring the expert insights on:

· Improving and optimising site management and overall productivity of clinical operations

· Working with limited budget to ensure on time study completion

· Escalating patient recruitment and improving patient retention to save cost and reduce lead-time

· Maximising trials results through overseas multinational/multi-centric trials

· Avoiding potential pitfalls of trials agreement

· Motivating and managing clinical project teams to improve timeline and progress

· Securing buy-ins and commitment from investigators to prevent costly delays

· Partnering with SMOs to increase the effectiveness of trial site management

· Gaining insights on future forwards of clinical trials in Asia and valuing its potential

· Attracting and retaining clinical talent pool to minimise turnover in clinical studies

· Exploring the feasibility of Phase I clinical trials in Asia

For event brochure, please contact:

Event Contact
Contact Name: Tan Peng Pheng

marcus evans,CP 21, Suite 2101,Central Plaza,
34 Jalan Sultan Ismail,
50250 Kuala Lumpur,Malaysia.

Telephone: +603.2723.6614
Fax: +603.2723.6699
Email: [email protected]

http://www.marcusevans.com/html/eventdetail.asp?eventID=13308&SectorID=3...